Triple
T10214689
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Avsola |
E242411
|
entity |
| Predicate | hasInternationalNonproprietaryName |
P24556
|
FINISHED |
| Object |
infliximab-axxq
Infliximab-axxq is a monoclonal antibody biosimilar to infliximab used to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
|
E851093
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69d381ae26c48190985abd0e25ee5d04 |
elicitation | completed |
| NER | batch_69d3aa273bdc8190bc4cf67a7923cebc |
ner | completed |
| NED1 | batch_69d6f6f4d0cc8190ae41277b15b3012d |
ned_source_triple | completed |
| NED2 | batch_69d6fd10dbc08190a297073e1b737566 |
ned_description | completed |
| NEDg | batch_69d6fa2bb2ec8190aa099988a6c225eb |
nedg | completed |
Created at: April 6, 2026, 11:04 a.m.